CareMetx, LLC

Today we're announcing the launch of our next-generation CRM platform, built on P3 Technology with proprietary CareMetx enhancements. For 15 years, we've served our pharmaceutical brand partners with one unwavering mission: transform complexity into clarity so patients can access life-changing specialty therapies faster and more seamlessly. The challenge we're solving: The patient access journey is fragmented by design. Payers, providers, pharmacies, and manufacturers operate in disconnected systems. Our approach: Move from reactive coordination to proactive orchestration. We've built on P3 Technology's foundation and enhanced it with proprietary CareMetx capabilities—custom data models, specialized integrations, and our intelligence layer—enabling real-time data synchronization, actionable intelligence, and next-best-action guidance across every stakeholder. What we've accomplished: ✓ Successfully launched first manufacturer brands on new platform ✓ Executing comprehensive migration plan for all existing customers by year-end ✓ Maintaining zero disruption to ongoing programs using proven portfolio cutover methodology This isn't just technology modernization. With the launch of our new connection layer in 2024 and now a new CRM built on P3 Technology, we have a foundation for continuous innovation: A living system where every stakeholder is connected, every interaction creates intelligence, and every partner can be better through a shared, Collective Intelligence. Read the full announcement: https://hubs.la/Q0496bjF0 #PatientAccess #DigitalTransformation #HealthcareInnovation #CollectiveIntelligence

After a week at Informa Connect Access USA, our team kept coming back to the same idea: even as new capabilities continue to emerge, something more foundational still feels unresolved. We share that POV in our latest blog and would welcome your perspective: https://hubs.la/Q048CsBj0

It’s been a big year for CareMetx. Our team has been evolving how we think about patient access, with a focus on better coordination and orchestration across the journey. It’s a need we’re hearing more broadly across the industry, and one we’re already delivering on. At Asembia this year, we’re looking forward to sharing what that looks like in practice. If you’ll be there, we think it’s worth a conversation. Book time with us: https://hubs.la/Q048t2dd0

A closer look at why early preparation, not late-stage routing, is critical when foundation assistance becomes necessary: https://hubs.la/Q047Yvwp0

The most patient-centered foundation support models are not defined by how much effort they expend after access breaks down, but by how effectively they prevent delays from occurring in the first place. Read more in our latest blog: https://lnkd.in/e-ANfw_5

Patient support design isn’t just a vendor decision. It’s a strategic choice that shapes how providers navigate access and how quickly patients start therapy. Explore the discussion: https://hubs.la/Q046MxWv0

A new episode of Prescription for Better Access is out.   CareMetx Executive Chairman Mark Hansen and his co-host Scott Howell sit down with legal expert William Sarraille to unpack recent policy developments putting new pressure on the PBM model.   As the regulatory environment evolves, conversations like this are increasingly important for understanding how policy changes may reshape benefit design, transparency, and the broader patient access landscape.   Listen to the full episode below.

As coverage complexity grows, charitable foundations are being asked to stabilize an increasingly unpredictable access environment. Our latest blog examines how patient support programs can approach this challenge more strategically: https://lnkd.in/eJfdj3DK

Patient services leaders are navigating a more complex operating environment than ever before. Our latest report shares how organizations are structuring programs, deploying technology, and preparing for what comes next. Explore the insights: https://hubs.la/Q046drY00

Scott Genone and the CareMetx, LLC team recently dropped their 2026 Patient Services Report 👀 100+ patient access decision-makers surveyed. The headline: 85% say their data is accurate. But most can't actually use it in real time to trigger workflows or decisions. 60% running hybrid hub models. Technology enablement still uneven across the patient journey. Full report worth a read 👇 https://lnkd.in/d8byZfRi Source: CareMetx 2026 Patient Services Report, Drug Channels #PatientAccess #HubServices #LifeSciences